![Company logo](https://db-fastly.legal.io/job/66dba0767e29ed89e5ec1323/1725725715.jpeg?auto=webp)
Our mission is to make biology easier to engineer. Ginkgo is constructing, editing, and redesigning the living world in order to answer the globe’s growing challenges in health, energy, food, materials, and more. Our bioengineers make use of an in-house automated foundry for designing and building new organisms.
Our Corporate Legal Team is focused on providing creative solutions to help drive these groundbreaking endeavors at Ginkgo, and we’re seeking a talented, motivated, and energetic Corporate Counsel to join our team. In particular, you’ll support the growth of our cell engineering business by primarily providing legal support for M&A and other corporate development transactions, including the buildout of our internal AI capabilities. You will also support our foundry supply chains and operations, draft and negotiate agreements, engage with existing strategic partners, and more. With your legal experience in corporate development and strategic transactions, your role will be critical to Ginkgo’s success.
Responsibilities
- Transactions support for mergers, acquisitions and other strategic transactions, working collaboratively with Ginkgo’s Corporate Development team.
- Integration support post-merger, including rationalization of vendor agreements and other contracts, management of employee transition, administration of purchase agreement and tech transfer terms and other tasks or issues that may arise during integration.
- Management of multiple deals in a fast-paced, innovation-driven environment.
- Engagement with senior leadership on legal considerations for strategic transactions.
- Field questions from stakeholders throughout the organization, such as communications teams, investor relations, technical teams and representatives from acquired companies.
- Operations support on legal issues and contracts as new technologies are integrated.
- Review documents, policies and agreements and provide legal advice and other support to internal teams at Ginkgo as may arise.
Minimum Requirements:
- Core competency in M&A and public company transactions and financings; J.D. degree and current bar membership in good standing; 3+ years legal experience, with strong preference for at least 3 years of law firm experience
- Humble approach to work allocation and a willingness to provide coverage to others during busy times
- Initiative-taking and self-directed to oversee and execute on the project at hand; ownership mentality is a cornerstone of our company culture
- Collaborative and communicative with a can-do attitude and good attention to detail
- Knowledge and understanding of different business-oriented approaches to transactions, with the ability to effectively evaluate legal exposure, manage risk, and achieve business goals within appropriate legal guidelines
- Experience with managing multiple, competing timelines in support of cross-functional teams; good time management skills, with a focus on pragmatic decision-making and efficient delivery of legal advice
- Nimble and adaptable to a dynamic work environment
- What is it really like to take your company public via a SPAC? One Boston biotech shares its journey (Fortune)
- Ginkgo Bioworks resizes the definition of going big in biotech, raising $2.5B in a record SPAC deal that weighs in with a whopping $15B-plus valuation (Endpoints News)
- Ginkgo Bioworks CEO on scaling up Covid-19 testing: ‘If we try, we can win’ (CNBC)
- Ginkgo raises $70 million to ramp up COVID-19 testing for employers, universities (Boston Globe)
- Ginkgo Bioworks Redirects Its Biotech Platform to Coronavirus (Wall Street Journal)
- Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response (PRNewswire)
- The Life Factory: Synthetic Organisms From This $1.4 Billion Startup Will Revolutionize Manufacturing (Forbes)
- Synthetic Bio Pioneer Ginkgo Raises $290 Million in New Funding (Bloomberg)
- Ginkgo Bioworks raises $350 million fund for biotech spinouts (Reuters)
- Can This Company Convince You to Love GMOs? (The Atlantic)